At RBS, our mission is to dismantle the critical manufacturing barriers that compromise cell therapy efficacy. By integrating gentle microfluidic encapsulation, real-time biosensing, and foundational AI models, we deliver ultra-high-accuracy sorting that virtually eliminates empty capsules and preserves full therapeutic potency. We compress iterative development from months to hours and scale production from micrograms to grams, enabling our partners to convert fragile regenerative innovations into robust, life-saving treatments for diabetes, liver disease, and beyond.